Welltower (WELL) Prices 17.5M Share Offering

Welltower Inc. (NYSE: WELL) announced today that it priced the public offering for the 17,500,000 shares of its common stock previously sold to BofA Securities, Inc. and Goldman Sachs & Co. LLC for aggregate gross proceeds to Welltower of approximately $1.5 billion. Welltower has also granted the underwriters an option to purchase up to 2,625,000 additional shares of common stock.

Welltower intends to use the net proceeds from the Offering for the acquisition of properties within the seniors housing and skilled nursing sectors, including those currently under contract and for general corporate purposes. On October 30, 2023, the Company disclosed approximately $1.0 billion of fully funded investments under contract and has entered into agreements to purchase an incremental $2.0 billion of properties as of November 6, 2023. In total, the $3.0 billion of granular acquisition activity is comprised of approximately $2.4 billion and $600 million of investments in the seniors housing and skilled nursing sectors, respectively. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.

BofA Securities, Inc. and Goldman Sachs & Co. LLC are acting as the underwriters of the Offering. A copy of the prospectus supplement and prospectus relating to these securities may be obtained (a) by contacting BofA Securities, Inc. NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, email: [email protected], or Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected] or (b) through the internet site of the SEC at http://www.sec.gov.

This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any offer or sale of, the common stock in any jurisdiction in which the offer, solicitation or sale of the notes would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Bolt Biotherapeutics acquires Prana Therapies, raises $120M
• Cboe Clear U.S. gets SEC registration to clear securities options
• Sierra Bancorp approves new buyback program, declares quarterly dividend